HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Caboodles

This article was originally published in The Rose Sheet

Executive Summary

Sarina Godin tapped director of marketing and product development, a new position, teen cosmetics company reports July 23. Effective immediately, Godin is responsible for overseeing marketing, product development and public relations for the Caboodles, she she and C me brands, Caboodles notes. Among primary goals will be significant boost in promotional activity and review of pricing strategies, Godin notes. Exec, who will report to interim CEO Charles Beech, comes to the firm from The Color Factory, a contract design and manufacturing cosmetics company. Prior to that, she was creative director for LVMH's Hard Candy brand, for which she led effort to convey a more mature brand image (1"The Rose Sheet" Feb. 26, 2001, p. 3)...

You may also be interested in...



Hard Candy Grows Up Under Parent LVMH

Hard Candy is repositioning its brand to convey a more mature, high-fashion image following a recent shift in management involving a reduced role for founder Dineh Mohajer at the company.

Stockwatch: Earnings Season Catches An Early Cold As Coronavirus Sweeps In

As industry bellwether J&J kicked-off 2019 fourth-quarter and full-year earnings season for life sciences companies, its financial results left investors feeling the cold. But with coronavirus envy sweeping a raft of smaller biotech companies, J&J may have the last laugh.

 

 

Pipeline Watch: Phase III Readouts For Surufatinib, Tislelizumab

Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.

 

UsernamePublicRestriction

Register

RS011400

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel